NYSE: CON

Concentra Group Holdings Parent (CON) Stock Analysis & Forecast

Sep 28 close

$35.36+0.35 (+1.0%)

Gekko Brief

AI summary

This week's only notable item is a comparison piece weighing Concentra Group (CON) against Medpace (MEDP) on value grounds, prompted by ongoing investor interest in medical services names. No results, guidance, deal or regulatory news accompanied the stock's move, and the comparison itself does not resolve the question it raises.

CON closed at $35.36, up 1% on the day, sitting above both its 50-day average of $33.85 and its 200-day average of $26.32, with the shorter average also above the longer one. The GekkoIndex reads 55.2, placing the stock in the Neutral zone, little changed over the past five sessions. Price remains 6.9% below the Gekko Fair Value estimate of $37.97.

The next earnings report is scheduled for 5 November 2026 after the close, 37 days out and beyond a typical 20-trading-day holding window; the prior report on 7 May 2026 saw EPS of $0.40 against a $0.34 estimate, with a 5.9% reaction, and the company has beaten estimates in 5 of the last 8 quarters. No insider, Congress, or unusual options activity appears in the current windows, and seasonality data is insufficient for a read. Consensus analyst target sits at 41, implying 16% upside from current levels.

Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.

Concentra Group Holdings Parent price vs fair value

$37.97$35.36Sep ’25Mar ’26Sep ’26
Close $35.36200-day averageGekko Fair Value $37.97

Concentra Group Holdings Parent quick facts

Market cap
$4.52B
P/E ratio
22.5
Forward P/E
18
EPS, TTM
$1.54
Revenue, TTM
$2.29B
Profit margin
8.7%
Dividend yield
0.72%
Beta
0.63
Volume
587,780 avg 947,148
1-year return
+71.8%
Typical daily move
±2.6%
Typical 20-day move
±5.9%
50-day average
$33.85
200-day average
$26.32
Next earnings
Nov 5 after close
Shares outstanding
127.5M
52-week range
$18.55$36.71

Concentra Group Holdings Parent swing-trade checklist

Concentra Group Holdings Parent scores 3 supportive, 1 mixed and 0 headwinds across the 4 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive1 mixed0 headwinds

  • Trendsupportive

    Above 50 and 200-day

    Close $35.36 is above the 50-day ($33.85) and 200-day ($26.32) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    55.2, Neutral

    Reading 55.2 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    6.9% below

    Price is 6.9% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 37 days

    Next report Nov 5, 2026, 37 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalityno data

    No data

    Not enough years of history for a seasonal read.

A description of current data, not a recommendation. How this page works

Concentra Group Holdings Parent stock chart and price history

Concentra Group Holdings Parent closed at $35.36 on Sep 28, 2026, +71.8% over the past year, inside a 52-week range of $18.55 to $36.71.

Close50-day average200-day averageVolume
Concentra Group Holdings Parent share price, past year, with 50-day and 200-day moving averages and volume$20$25$30NovDecJan 2026FebMarAprMayJunJulAugSep35.36

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+1.9%
3 months
+18.8%
6 months
+67.4%
1 year
+71.8%
The full CON chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CON in Gekko

Follow Concentra Group Holdings Parent through every session

Put CON on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track CON in GekkoFree for 7 days. No credit card required.

About Concentra Group Holdings Parent

Concentra Group Holdings Parent runs health services aimed at people hurt or affected on the job, serving businesses across the United States. Its offerings span care for workplace injuries, walk-in urgent treatment, lab and imaging testing, checkups meant to catch problems early, and programs built around what individual employers need, plus efforts to keep workers well overall. Patients get to these services through a set of clinics dedicated to occupational care and locations placed directly at employer worksites, which has made the company a familiar name in this space.

The company also runs a few more targeted offerings. Concentra Telemed lets people get remote care for job-related injuries and illnesses while giving employers extra support options. Concentra Pharmacy handles medication needs, and Concentra Medical Compliance Administration acts as an outside manager for employer drug testing programs, covering both workforces under regulation and those without such requirements. Its clients are largely companies looking to handle health and testing obligations for their staff, and the firm sits under Select Medical Corporation as a subsidiary.

The company traces back to 1979 and runs its operations from Mechanicsburg, Pennsylvania. Shares trade on the NYSE under the ticker CON.

Listed
NYSE
Sector
Health services
Industry
Medical/Nursing services
Website
concentra.com

Concentra Group Holdings Parent GekkoIndex: the smart money zone

Concentra Group Holdings Parent’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 55.2, in the Neutral zone, down 0.2 points over five sessions.

010055.2Neutral

Down 0.2 points over five sessions.

Reading for Sep 28, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying10+3.7%+4.0%+1.1%+9.3%
Accumulation200+0.4%+1.2%+2.7%+5.4%
Neutral (current zone)267+0.4%+0.6%+1.6%+4.5%
Distribution61+0.7%+1.6%+1.4%+2.2%
Selling2Too few readings yet

Average CON share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the CON price, zone by zone.Track CON in Gekko

Is Concentra Group Holdings Parent stock overvalued? Gekko Fair Value

Concentra Group Holdings Parent trades 6.9% below Gekko Fair Value of $37.97, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Concentra Group Holdings Parent shares are worth, recalculated every trading day.

$37.97

Gekko Fair Value, Sep 26, 2026

6.9% Undervalued

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open CON in Gekko

Concentra Group Holdings Parent insider and Congress trading

No open-market insider purchases were filed for Concentra Group Holdings Parent, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for CON in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every CON insider filing, plotted on the chart in Gekko.Open CON in Gekko

Congress trades last 90 days

No trades in CON were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for CON, plotted on the chart in Gekko.Open CON in Gekko

Buybacks

Concentra Group Holdings Parent has been buying back its own shares.

Bought back, quarter ended Jun 30, 2026
$10.96M
As a share of market cap
0.24%

From company filings.

Hedge funds and billionaires quarter ended Dec 31

0of the funds Gekko tracks hold CON.

0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko

Concentra Group Holdings Parent earnings: next date and track record

Concentra Group Holdings Parent reports on Nov 5, 2026, after the close (37 days away), and beat the EPS estimate in 5 of its last 8 reports.

5 of 8reports beat the EPS estimate
±3.1%average move across the report
3 of 8reports followed by a gain

Share-price move across each report

−2.8%Aug ’24−3.4%Oct ’24−0.6%Mar ’25−2.7%May ’25+8.4%Aug ’25+1.0%Nov ’25−0.3%Jan ’26+5.9%May ’26

Last earnings call, May 7, 2026 AI summary

What they said
Management presented a strong Q1 2026 for Concentra Group Holdings Parent, Inc., highlighting 13.7% total revenue growth to $569.6M (6.3% ex-acquisitions) and a 6.7% increase in average patient visits per day. Workers' compensation volume and rate growth were key drivers, with workers' comp visits per day up 9.6% and revenue per visit up 2.0; employer services also grew. Management credited improved patient satisfaction metrics, center service levels, technology investments, and account management/prospecting for retention and new business wins. The company referenced weather as a net positive in Q1. Cost control and staffing execution contributed to margin/adjusted EBITDA outperformance versus consensus. Management noted strong free cash flow conversion, raised FCF guidance alongside an increased EBITDA guide, and maintained full-year CapEx guidance of $70-80M. Strategic highlights included integration of Nova and Pivot acquisitions, rapid growth of the on-site portfolio (approaching $150M, 20% growth ex-Pivot), pipeline for de novos and selective M&A, and opportunity areas in advanced primary care on-sites. Near-term catalysts include state-level fee schedule updates (e.g., Tennessee, potential NY updates) and ongoing deleveraging/decoupling from Select.
Guidance
Management raised free cash flow guidance and raised their EBITDA guidance (exact numeric figures not disclosed on the call). CapEx guidance remains $70 million to $80 million for the full year. Revenue per visit guidance remains roughly +3% for the year (management said 'on track' for 3% and potentially higher). They also noted expected meaningful fee schedule updates in Tennessee in Q2 and routine state updates through summer/fall; about 75-80% of fee schedule adjustments typically occur in Q1.
Risks flagged
Risks cited or implied: variability in weather and its impact on visit volume; uncertainty/timing of state workers' compensation fee schedule changes (e.g., New York unresolved); macroeconomic and employment trends that affect employer services demand; integration and execution risks from acquisitions (Nova, Pivot) and timing to fully embed contributions; need to manage deleveraging and final decoupling from Select; potential center closures due to severe weather; and longer horizon/timing risk for onshoring/manufacturing tailwinds.
ReportedEPSSurpriseRevenueSurpriseMove
May 7, 2026$0.40
est $0.34
+17.6%$569.6M
est $553.5M
+2.9%+5.9%
Jan 28, 2026$0.28
est $0.23
+21.7%$539.1M
est $532.1M
+1.3%−0.3%
Nov 6, 2025$0.39
est $0.38
+2.6%$572.8M
est $532.0M
+7.7%+1.0%
Aug 7, 2025$0.37
est $0.37
0.0%$550.8M
est $537.4M
+2.5%+8.4%
May 7, 2025$0.32
est $0.32
0.0%$500.8M
est $496.1M
+0.9%−2.7%
Mar 3, 2025$0.17
est $0.17
0.0%$465.0M
est $486.6M
−4.4%−0.6%
Oct 31, 2024$0.37
est $0.36
+2.8%$489.6M
est $492.6M
−0.6%−3.4%
Aug 1, 2024$0.50
est $0.49
+2.0%$477.9M
est $473.7M
+0.9%−2.8%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Concentra Group Holdings Parent stock forecast and analyst price targets

Analysts’ average 12-month price target for Concentra Group Holdings Parent is $41.00, +16.0% from the last close.

$41.00consensus 12-month target, +16.0% from the last close
+1.6%average 20-day move after past Neutral readings
±2.6%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Concentra Group Holdings Parent market cap and key statistics

Concentra Group Holdings Parent’s market cap is $4.52B, with a P/E ratio of 22.5 and revenue of $2.29B over the last twelve months.

Valuation

Market cap
$4.52B
P/E ratio
22.5
Forward P/E
18
EPS, TTM
$1.54
Gekko Fair Value
$37.97

Trading

Volume
587,780
Avg volume, 20 days
947,148
52-week high
$36.71
52-week low
$18.55
Shares outstanding
127.5M

Financials

Revenue, TTM
$2.29B
Profit margin
8.7%
Return on equity
47.1%
Quarterly earnings growth, YoY
+47.0%

Risk and income

Beta
0.63
Typical daily move
±2.6%
Typical 20-day move
±5.9%
Dividend yield
0.72%

Concentra Group Holdings Parent stock news this week

1 headline about Concentra Group Holdings Parent from the past week, newest first, each linking to the publisher.

Concentra Group Holdings Parent peers

Concentra Group Holdings Parent’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
LHLabcorp+0.9%Accumulation3.9% below
GHGuardant Health+1.4%Neutral0.5% above
SOLVSolventum+0.6%Neutral16.4% below
EHCEncompass Health+0.5%Neutral7.6% above
DVADaVita−0.4%Accumulation15.9% below
BTSGBrightSpring Health Services+0.8%Accumulation7.4% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

Concentra Group Holdings Parent stock FAQ

What is Concentra Group Holdings Parent’s market cap?

Concentra Group Holdings Parent’s market cap is $4.52B at the Sep 28, 2026 close of $35.36, with 127.5M shares outstanding. The shares trade on a P/E ratio of 22.5.

What is the Concentra Group Holdings Parent stock forecast?

The consensus analyst 12-month price target for Concentra Group Holdings Parent is $41.00, +16.0% from the last close. Gekko doesn’t publish price predictions of its own.

Is Concentra Group Holdings Parent stock overvalued or undervalued?

On Gekko’s estimate Concentra Group Holdings Parent is undervalued: the Sep 28, 2026 close of $35.36 is 6.9% below Gekko Fair Value of $37.97. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Concentra Group Holdings Parent report earnings next?

Concentra Group Holdings Parent is expected to report on Nov 5, 2026, after the market closes (37 days away). Analysts expect earnings of $0.45 per share on revenue of $605.2M. Concentra Group Holdings Parent beat the earnings estimate in 5 of its last 8 reports, moving 3.1% on average across the report.

What is Concentra Group Holdings Parent’s 52-week high and low?

Concentra Group Holdings Parent’s 52-week high is $36.71 and its 52-week low is $18.55; it closed at $35.36 on Sep 28, 2026, +71.8% over the past year.

Is Concentra Group Holdings Parent stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 4 items with data read as supportive (trend, fair value and earnings risk), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Concentra Group Holdings Parent the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,380 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.